SISC-Poster
Vol. 35 No. S1 (2025): 39° Conference of the Italian Society for the Study of Headaches (SISC)

PO-49 | Distress perception and mutuality in caregivers of migraine patients with depressive symptoms.: baseline evaluation of the observational prospective real-life MiDEAR study to evaluate the effectiveness of fremanezumab for reducing the caregivers’ burden a

C. Altamura,1 L. Fofi,1 R. Ornello,2 G. Ceccardi,3 C. Aurilia,4 A. Montisano,5 I. Orologio,6 D. Mascarella,7 G. Viticchi,8 M. Marcosano,1 N. Brunelli,1 G. Del Mastro,1 A. Onofri,2 A. Lanfranchi,3 G. Fiorentini,4 M. Silvestro,6 V. Favoni,7 G. Egeo,4 M. Silvestrini,8 M. Peresson,9 S. Cevoli,7 A. Russo,6 R. Rao,3 L. Grazzi,5 S. Sacco,2 F. Vernieri1 | 1Fondazione Policlinico Universitario Campus Bio-Medico, Rome; 2University of L'Aquila, L’Aquila; 3ASST Spedali Civili di Brescia, Brescia; 4IRCCS San Raffaele, Rome; 5IRCCS Fondazione istituto Neurologico Carlo Besta, Milan; 7IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna; 6University of Campania; Caserta; 8Marche Polytechnic University, Ancona; 9San Pietro Fatebenefratelli Hospital, Rome, Italy

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 6 November 2025
78
Views
0
Downloads

Authors

Background: Migraine is a very disabling disease that negatively impacts not only patients’ but also their family members’ daily life. While the role (figure) of the caregiver is central to various neurological pathologies, it has scarcely been taken into consideration in migraine. The aim of the present study is to evaluate distress perception and mutuality in caregivers of migraine patients with depressive symptoms.

Methods: This is a multicenter, observational, study involving adult patients with migraine receiving fremanezumab with symptoms of depression (PHQ-9 ≥5) and their caregivers. At baseline, monthly migraine days (MMDs), acute medications (MAMs), pain intensity (NRS), migraine-related disability (MIDAS; HIT6), and depressive symptoms (PHQ-9) were evaluated in migraine patients, while perceived stress (Relatives Stress Scale -RSS) was measured in caregivers and reciprocity in the dyad (Mutuality Scale MS).

Results: The MI-DEAR study has been ongoing since October 2024, and currently 116 dyads have been enrolled (patients: 83.2% females, 43.9 ys, SD 1.2; caregivers: 34.5% females, 48.7 ys, SD 1.1). Of these, 38 dyads completed the 6-month follow-up. Caregivers were the patients’ partners in 80.5% of cases, parents in 12.4%, daughters in 2.7%, and sisters in 1.8%.  At baseline, patients reported 15 SD 6.9 MMDs with a severe disability (HIT-6 65.5 SD 8.5, and MIDAS 66.8 SD 51.7), and moderate symptoms of depression (PHQ-9 11 SD 5 SD5.1). Caregivers presented moderate distress (RSS 20.37, SD 11.3). Mutuality scales scores were high in patients (3.0, SD 0.6) and caregivers. (3.2 SD 0.5). At baseline, MMDs were related to PHQ scores (p = 0.009) but not directly to MS in patients and caregivers, or to RRS scores (p consistently > 0.1). Conversely, RRS scores were associated with PHQ-9 scores (p=0.004), MIDAS (p=0.021), and inversely related to MS in patients (p=0.009) and caregivers (p< 0.001).

Conclusion: Caregivers of patients with disabling migraine present a moderate burden of perceived stress, which is associated with patients' depressive symptoms and negatively affects mutuality in the couple.

Downloads

Download data is not yet available.

Citations

no refs

How to Cite



1.
PO-49 | Distress perception and mutuality in caregivers of migraine patients with depressive symptoms.: baseline evaluation of the observational prospective real-life MiDEAR study to evaluate the effectiveness of fremanezumab for reducing the caregivers’ burden a: C. Altamura,1 L. Fofi,1 R. Ornello,2 G. Ceccardi,3 C. Aurilia,4 A. Montisano,5 I. Orologio,6 D. Mascarella,7 G. Viticchi,8 M. Marcosano,1 N. Brunelli,1 G. Del Mastro,1 A. Onofri,2 A. Lanfranchi,3 G. Fiorentini,4 M. Silvestro,6 V. Favoni,7 G. Egeo,4 M. Silvestrini,8 M. Peresson,9 S. Cevoli,7 A. Russo,6 R. Rao,3 L. Grazzi,5 S. Sacco,2 F. Vernieri1 | 1Fondazione Policlinico Universitario Campus Bio-Medico, Rome; 2University of L’Aquila, L’Aquila; 3ASST Spedali Civili di Brescia, Brescia; 4IRCCS San Raffaele, Rome; 5IRCCS Fondazione istituto Neurologico Carlo Besta, Milan; 7IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna; 6University of Campania; Caserta; 8Marche Polytechnic University, Ancona; 9San Pietro Fatebenefratelli Hospital, Rome, Italy. Confinia Cephalal [Internet]. 2025 Nov. 6 [cited 2026 Jan. 29];35(S1). Available from: https://www.confiniacephalalgica.com/site/article/view/15871